200 related articles for article (PubMed ID: 19737967)
1. Mutations in multiple domains of c-Myb disrupt interaction with CBP/p300 and abrogate myeloid transforming ability.
Pattabiraman DR; Sun J; Dowhan DH; Ishii S; Gonda TJ
Mol Cancer Res; 2009 Sep; 7(9):1477-86. PubMed ID: 19737967
[TBL] [Abstract][Full Text] [Related]
2. A functional SUMO-interacting motif in the transactivation domain of c-Myb regulates its myeloid transforming ability.
Saether T; Pattabiraman DR; Alm-Kristiansen AH; Vogt-Kielland LT; Gonda TJ; Gabrielsen OS
Oncogene; 2011 Jan; 30(2):212-22. PubMed ID: 20802522
[TBL] [Abstract][Full Text] [Related]
3. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
Schmidt M; Koller R; Haviernik P; Bies J; Maciag K; Wolff L
Oncogene; 2001 Sep; 20(43):6205-14. PubMed ID: 11593429
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional activation potential of normal and tumor-associated myb isoforms does not correlate with their ability to block GCSF-induced terminal differentiation of murine myeloid precursor cells.
Patel G; Tantravahi R; Oh IH; Reddy EP
Oncogene; 1996 Sep; 13(6):1197-208. PubMed ID: 8808694
[TBL] [Abstract][Full Text] [Related]
5. Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation.
Kitabayashi I; Yokoyama A; Shimizu K; Ohki M
EMBO J; 1998 Jun; 17(11):2994-3004. PubMed ID: 9606182
[TBL] [Abstract][Full Text] [Related]
6. Insertional mutagenesis and transformation of hematopoietic stem cells.
Ihle JN; Morishita K; Matsugi T; Bartholomew C
Prog Clin Biol Res; 1990; 352():329-37. PubMed ID: 2169632
[TBL] [Abstract][Full Text] [Related]
7. Bromodomain and histone acetyltransferase domain specificities control mixed lineage leukemia phenotype.
Santillan DA; Theisler CM; Ryan AS; Popovic R; Stuart T; Zhou MM; Alkan S; Zeleznik-Le NJ
Cancer Res; 2006 Oct; 66(20):10032-9. PubMed ID: 17047066
[TBL] [Abstract][Full Text] [Related]
8. c-Myb acetylation at the carboxyl-terminal conserved domain by transcriptional co-activator p300.
Tomita A; Towatari M; Tsuzuki S; Hayakawa F; Kosugi H; Tamai K; Miyazaki T; Kinoshita T; Saito H
Oncogene; 2000 Jan; 19(3):444-51. PubMed ID: 10656693
[TBL] [Abstract][Full Text] [Related]
9. Histone H3 tail positioning and acetylation by the c-Myb but not the v-Myb DNA-binding SANT domain.
Mo X; Kowenz-Leutz E; Laumonnier Y; Xu H; Leutz A
Genes Dev; 2005 Oct; 19(20):2447-57. PubMed ID: 16195416
[TBL] [Abstract][Full Text] [Related]
10. TEL2, an ETS factor expressed in human leukemia, regulates monocytic differentiation of U937 Cells and blocks the inhibitory effect of TEL1 on ras-induced cellular transformation.
Kawagoe H; Potter M; Ellis J; Grosveld GC
Cancer Res; 2004 Sep; 64(17):6091-100. PubMed ID: 15342392
[TBL] [Abstract][Full Text] [Related]
11. Redundant functions of B-Myb and c-Myb in differentiating myeloid cells.
Golay J; Broccoli V; Borleri GM; Erba E; Faretta M; Basilico L; Ying GG; Piccinini G; Shapiro LH; Lovrić J; Nawrath M; Mölling K; Rambaldi A; Introna M
Cell Growth Differ; 1997 Dec; 8(12):1305-16. PubMed ID: 9419419
[TBL] [Abstract][Full Text] [Related]
12. Interaction of the co-activator CBP with Myb proteins: effects on Myb-specific transactivation and on the cooperativity with NF-M.
Oelgeschläger M; Janknecht R; Krieg J; Schreek S; Lüscher B
EMBO J; 1996 Jun; 15(11):2771-80. PubMed ID: 8654374
[TBL] [Abstract][Full Text] [Related]
13. Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation.
Aikawa Y; Nguyen LA; Isono K; Takakura N; Tagata Y; Schmitz ML; Koseki H; Kitabayashi I
EMBO J; 2006 Sep; 25(17):3955-65. PubMed ID: 16917507
[TBL] [Abstract][Full Text] [Related]
14. Transactivation of cytosolic alanine aminotransferase gene promoter by p300 and c-Myb.
Anemaet IG; González JD; Salgado MC; Giralt M; Fernández F; Baanante IV; Metón I
J Mol Endocrinol; 2010 Sep; 45(3):119-32. PubMed ID: 20573775
[TBL] [Abstract][Full Text] [Related]
15. Structures of KIX domain of CBP in complex with two FOXO3a transactivation domains reveal promiscuity and plasticity in coactivator recruitment.
Wang F; Marshall CB; Yamamoto K; Li GY; Gasmi-Seabrook GM; Okada H; Mak TW; Ikura M
Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6078-83. PubMed ID: 22474372
[TBL] [Abstract][Full Text] [Related]
16. The ability of E1A to rescue ras-induced premature senescence and confer transformation relies on inactivation of both p300/CBP and Rb family proteins.
Deng Q; Li Y; Tedesco D; Liao R; Fuhrmann G; Sun P
Cancer Res; 2005 Sep; 65(18):8298-307. PubMed ID: 16166306
[TBL] [Abstract][Full Text] [Related]
17. Interaction of c-Myb with p300 is required for the induction of acute myeloid leukemia (AML) by human AML oncogenes.
Pattabiraman DR; McGirr C; Shakhbazov K; Barbier V; Krishnan K; Mukhopadhyay P; Hawthorne P; Trezise A; Ding J; Grimmond SM; Papathanasiou P; Alexander WS; Perkins AC; Levesque JP; Winkler IG; Gonda TJ
Blood; 2014 Apr; 123(17):2682-90. PubMed ID: 24596419
[TBL] [Abstract][Full Text] [Related]
18. DNA binding-independent transcriptional activation of the vascular endothelial growth factor gene (VEGF) by the Myb oncoprotein.
Lutwyche JK; Keough RA; Hunter J; Coles LS; Gonda TJ
Biochem Biophys Res Commun; 2006 Jun; 344(4):1300-7. PubMed ID: 16650815
[TBL] [Abstract][Full Text] [Related]
19. Murine myeloid leukemic cells with disrupted myb loci show splicing anomalies that account for heterogeneous sizes in myb proteins.
Tantravahi R; Dudek H; Patel G; Reddy EP
Oncogene; 1996 Sep; 13(6):1187-96. PubMed ID: 8808693
[TBL] [Abstract][Full Text] [Related]
20. HIPK1 interacts with c-Myb and modulates its activity through phosphorylation.
Matre V; Nordgård O; Alm-Kristiansen AH; Ledsaak M; Gabrielsen OS
Biochem Biophys Res Commun; 2009 Oct; 388(1):150-4. PubMed ID: 19646965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
